Decoding the Tri-Layered Transcriptomic Architecture of Breast Cancer: An Integrative Review of Host Gene Expression, Intratumoral Microbiomics, Microbe-Induced Fusion Mechanisms, and Low-Cost Precision Oncology

Breast cancer is a profoundly heterogeneous malignancy whose clinical progression, therapeutic resistance, and recurrence cannot be fully deciphered through isolated host mutational profiling alone. Advances in paired-end next-generation RNA sequencing (RNA-Seq) demonstrate that a single tumor transcriptome captures multiple overlapping biological layers beyond canonical messenger RNA abundance. This review presents an integrative conceptual framework that unifies three critical dimensions of breast cancer bioinformatics: (1) host transcriptional reprogramming across molecular subtypes; (2) the compositional and functional dynamics of the intratumoral microbiome extracted from non-human sequence reads; and (3) structural genomic rearrangements generating oncogenic chimeric fusion transcripts. Building upon evidence from large-scale cohorts such as The Cancer Genome Atlas (TCGA) and high-specificity fusion pipelines (e.g., SnowShoes-FTD), this article introduces a novel mechanistic hypothesis—the Microbe-Induced Promoter-Swap (MIPS) model—proposing that genotoxin-producing intratumoral bacteria (such as colibactin-synthesizing Proteobacteria) catalyze double-strand DNA breaks at open chromatin hubs, accelerating non-random promoter-swap fusions (e.g., WIPF2-ERBB2 and ARID1A-MAST2). Furthermore, this review outlines a two-arm in silico and 3D mammary organoid validation blueprint alongside a low-cost, single-assay translational roadmap designed to democratize precision breast cancer diagnostics and microbiome-targeted therapeutics in resource-limited healthcare settings.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24332327
Primary Topic
Cancer Genomics and Diagnostics
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Decoding the Tri-Layered Transcriptomic Architecture of Breast Cancer: An Integrative Review of Host Gene Expression, Intratumoral Microbiomics, Microbe-Induced Fusion Mechanisms, and Low-Cost Precision Oncology

Megha Ghosal
1 links
Zenodo (CERN European Organization for Nuclear Research)
Cancer Genomics and Diagnostics
preprint

Decoding the Tri-Layered Transcriptomic Architecture of Breast Cancer: An Integrative Review of Host Gene Expression, Intratumoral Microbiomics, Microbe-Induced Fusion Mechanisms, and Low-Cost Precision Oncology

Megha Ghosal
preprint en

Abstract

Breast cancer is a profoundly heterogeneous malignancy whose clinical progression, therapeutic resistance, and recurrence cannot be fully deciphered through isolated host mutational profiling alone. Advances in paired-end next-generation RNA sequencing (RNA-Seq) demonstrate that a single tumor transcriptome captures multiple overlapping biological layers beyond canonical messenger RNA abundance. This review presents an integrative conceptual framework that unifies three critical dimensions of breast cancer bioinformatics: (1) host transcriptional reprogramming across molecular subtypes; (2) the compositional and functional dynamics of the intratumoral microbiome extracted from non-human sequence reads; and (3) structural genomic rearrangements generating oncogenic chimeric fusion transcripts. Building upon evidence from large-scale cohorts such as The Cancer Genome Atlas (TCGA) and high-specificity fusion pipelines (e.g., SnowShoes-FTD), this article introduces a novel mechanistic hypothesis—the Microbe-Induced Promoter-Swap (MIPS) model—proposing that genotoxin-producing intratumoral bacteria (such as colibactin-synthesizing Proteobacteria) catalyze double-strand DNA breaks at open chromatin hubs, accelerating non-random promoter-swap fusions (e.g., WIPF2-ERBB2 and ARID1A-MAST2). Furthermore, this review outlines a two-arm in silico and 3D mammary organoid validation blueprint alongside a low-cost, single-assay translational roadmap designed to democratize precision breast cancer diagnostics and microbiome-targeted therapeutics in resource-limited healthcare settings.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon